Metabolic syndrome as a growing problem of population in clinical and epidemiological perspectives

• Дата: 2012
• Автор: Rutowski, J.A.
• Формат: Стаття
• Мова: English
• Опубліковано: Фізико-хімічний інститут ім. О.В. Богатського НАН України 2012
• Назва видання: Актуальні проблеми транспортної медицини
• Теми: Клинические аспекты медицины транспорта
• Онлайн доступ: http://dspace.nbuv.gov.ua/handle/123456789/136443
• Назва журналу: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Цитувати: Metabolic syndrome as a growing problem of population in clinical and epidemiological perspectives / J.A. Rutowski // Актуальні проблеми транспортної медицини. — 2012. — № 3 (29). — С. 123-128. — Бібліогр.: 19 назв. — англ.

Metabolic syndrome is a conglomeration of factors that contribute to the development of atherosclerotic plaque. As of obesity, which is one of the diagnostic criteria of metabolic syndrome by hypertension and atherogenic dyslipidemia all these elements contribute to the development of atherosclerosis. It is commonly believed that the development of metabolic syndrome are responsible genetic predisposition and environmental factors, which consist of such calories and atherogenic diet and low physical activity. The prevalence of metabolic syndrome in populations is diverse in terms of ethnicity, age and gender. It is characterized by obesity, hypertension, type 2 diabetes, insulin resistance and lipid disorders. Effects and risks of particular types of diseases and disorders are mutually enhancing and adding up, which increases risk of adverse complications. According to World Health Organization (WHO) data in the 6 billion people in the world, 175 million have diabetes, and expects that over the next 25 years this number will increase to 250 million. Despite therapeutic advances, diabetes is not to cure disease that causes disability and shortens the average duration of life of patients by 20-30%. It is estimated that the treatment of diabetes and its complications consumes about 7% of all material expenditures on health care in Poland. In the United States of America, over 65% of people suffer from obesity, in Europe, this problem affects more than 67% of the population. It is estimated that in Poland about 20% or more of adults are obese. European Group for the Study of Insulin resistance (EGIR), based on WHO criteria, in several populations of different European countries assessed the occurrence of this syndrome in persons aged 40 - 55 years 7 - 36% in men and 5 - 22% in women. Data on the prevalence of metabolic syndrome in Poland was obtained from the study and obtained in corresponding WOBASZ study. In both studies the prevalence of metabolic syndrome was assessed NCEP - ATP III in 2001 and the most recent version of 2005. Based on these data, it appears that metabolic syndrome occurs on average every fifth of an adult, almost 6 million Polish citizens.